Understanding Prescription Drug Monitoring Programs (PDMP or PMP)

Prescription Drug Monitoring Programs, typically referred to as a “PDMP” or “PMP”, are state-operated electronic databases designed to monitor the prescribing and dispensing of controlled substances (schedule II-V) within a state, commonwealth, district, or territory (jurisdiction). Depending on where you practice, PMPs may also track non-federally scheduled “drugs of concern”, which have been identified as at increased risk for misuse, abuse and/or addiction in addition to controlled substances. Some of the common “drugs of concern” required to be reported to PMPs include gabapentin, proin, and xylazine within the veterinary industry.

The terms “PMP” and “PDMP” are used interchangeably, and both refer to the same regulatory framework. PDMPs are limited to collecting prescribing and dispensing data within one jurisdiction; however, many jurisdictions share PMP information across state lines through the national NABP PMP InterConnect System. Since PDMPs are managed by jurisdiction, registration, reporting, and access requirements can vary significantly according to applicable law. While various jurisdictions have begun forming PMP alliances, particularly within specific regions, no unified PMP framework exists.

Federal oversight does not apply to PMP databases. These programs are controlled entirely by the jurisdictions in which they operate; however, federal agencies do access PMP information for law enforcement and investigative purposes as needed.

Prescription Monitoring Program Use

PMPs databases are utilized by pharmacies, healthcare providers, and law enforcement officials to review, monitor, and track patient prescribing and dispensing information for controlled substances and “drugs of concern”. Just as every jurisdiction has the right to implement PMP database requirements according to its governing laws, they also have the right to decide who those requirements apply to, and to what extent those requirements apply.

Purpose of Prescription Monitoring Programs

In the veterinary industry, states like Connecticut require veterinarians to use the PMP like human healthcare providers do, i.e. reviewing a patient’s medical records in the Connecticut Prescription Monitoring and Reporting System (CPMRS) prior to prescribing more than a 72-hour supply of schedule II-V controlled substances, reporting controlled substance dispensing, and querying the CPMRS at least once every 90 days when ongoing controlled substance treatment is prescribed. In contrast, states such as Georgia, Pennsylvania, and the District of Columbia only require veterinarians to register with the PMP. If you are a veterinarian in California, registration with the Controlled Substance Utilization Review and Evaluation System (CURES) is the only requirement if you do not dispense. If you do dispense, you must report dispensing to CURES every seven days; including filing “zero” reports if no dispensing occurs within that period. Some states like Wyoming only require veterinarians to enroll as data requesters, while others like Missouri specifically exclude veterinarians from enrolling as a data requester. There are also others like Arizona, Illinois, Delaware, and New York that exempt veterinarians from using PMP databases entirely. 

When it comes to PMP requirements, every jurisdiction is different, and those differences become more varied in the veterinary industry. Being informed about the prescription drug monitoring program in the state where you practice is important. As a veterinarian, it is even more important to understand the specific PMP requirements that apply to you according to your scope of practice within the profession.

Purpose of Prescription Monitoring Programs

Prescription drug monitoring programs were originally created to track prescription opiates. The earliest PDMP was introduced in New York under the Boylan Act in 1918. California has the oldest, continuously operating PDMP that has been in effect since 1939.

Since then, the use of PDMPs for tracking purposes has continued across the United States, assisting jurisdictions in numerous ways. PDMPs still track prescription opioids and have expanded to tracking countless other prescription medications. In doing so, PMPs play a key role in the prevention of drug diversion as well as protection against potentially fraudulently obtained prescriptions for controlled substances and other medications at risk for abuse, misuse, and addiction. 

The data PMPs collect serves a purpose by increasing overall prescribing and dispensing visibility. This visibility supports safer prescribing by allowing clinicians to access patient historical data before treatment decisions are made, and safer dispensing when pharmacies have access to patient prescription information, particularly when programs are comprehensive and routinely used. 

PDMPs serve a purpose by strengthening public health and safety measures through data surveillance. The collection, analysis, and reporting of data compiled by PDMPs is what allows public health authorities to monitor prescribing and dispensing trends to identify the geographic and demographic patterns that have the ability to indicate existing or emerging risks. This population-level visibility helps ensure that public health responses and policy decisions are well-informed within specific jurisdictions.

Evidence reviewed by the Centers for Disease Control and Prevention (CDC) indicates that PMP information can also serve another preventative purpose at the clinician level. According to the CDC, review of patient PMP information could help clinicians better identify patients who may be at risk for overdose more easily, providing an opportunity for potential lifesaving information to be shared and/or intervention. While PDMPs are not a standalone solution, they are recognized as a foundational tool for regulatory oversight and prescription drug diversion prevention.

Why PMP Requirements Matter for Veterinary Hospitals

Failing to comply with PMP requirements, which may include failing to register, check, or report to PMP databases, exposes veterinarians to various regulatory risks that can lead to significant consequences. For veterinary providers that are noncompliant, consequences can result in license suspension, fines and/or civil penalties. 

Additionally, when veterinarians do not comply with PMP requirements, it can result in patient care being compromised if prescription fraud goes undetected or diversion in the form of “doctor-shopping” occurs, and patient medication is diverted from a patient by the patient-client owner for illicit purposes.

As drug diversion, abuse, and addiction issues continue to increase across the country, state authorities are taking a stronger position on enforcing compliance with PMP requirements; viewing participation in PMP programs as an essential part of ongoing efforts to ensure that all licensed professionals are doing to prevent controlled substances and other drugs of concern from being diverted for illegal purposes.

Common Challenges With Prescription Monitoring Programs

Veterinary professionals are frequently challenged not only with understanding PMP databases and what is required of them based on where they practice, but also in how to ensure they meet those requirements. When asked about PDMP databases and utilization, many veterinarians frequently cite that meeting PMP requirements is an “administrative burden”. For veterinarians practicing in jurisdictions that require registering, consulting and reporting to a PDMP, many say that they do not have enough time or enough support staff  to complete all required tasks. These challenges are primarily operational and indicate a need for supplemental systems that can help support veterinarians by filling in gaps where internal inefficiencies exist.

How Automation Helps Address PMP Reporting Challenges

Automation has the potential to significantly reduce the operational friction associated with PMP reporting. By integrating controlled substance tracking directly into clinical and inventory workflows, CUBEX automated systems submit required data to state PDMPs without manual re-entry. This reduces the likelihood of errors and helps ensure reporting occurs within required timeframes, keeping veterinary hospitals inspection-ready without adding to staff workload.

Research evaluating PDMP effectiveness consistently emphasizes that ease of use and system integration are key factors influencing adoption and compliance. When reporting processes are streamlined, clinicians are more likely to engage with PDMP data and meet regulatory expectations without added administrative strain. CUBEX supports compliance by simplifying execution, not by eliminating responsibility. Your team gets the tools to stay accurate and audit-ready at all times.

PMP Accountability and Business Operations

Prescription Monitoring Programs play a critical role in the oversight of controlled substances and drugs of concern in the United States. Evidence shows that PDMPs can influence prescribing behavior and support diversion prevention depending on program design and implementation. For veterinarians and veterinary hospitals, understanding the specific PMP requirements that apply in their jurisdiction and adopting efficient prescription management systems to ensure those requirements are met is essential. CUBEX is purpose-built to support exactly that, offering DEA-aligned workflows and closed-loop documentation that adapt to compliance demands across all 50 states.

Automation offers a practical way for veterinarians to meet PMP requirements while minimizing time spent on ongoing tasks such as dispensing and reporting. With CUBEX's automated prescription management tools, dispensing data is submitted automatically and consistently, ensuring that veterinarians are adhering to PMP requirements, reducing operational risk, and freeing clinical staff to focus on patient care rather than paperwork.